Molecular structure of Oxociprofloxacin, CAS Number: 103237-52-1
Oxociprofloxacin (CAS 103237-52-1)
CAS Number:
103237-52-1
Purity:
≥96%
Molecular Weight:
345.33
Molecular Formula:
C17H16FN3O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
A metabolite of the fluorinated quinolone anti-bacterial Ciprofloxacin. Oxociprofloxacin is a derivative of the fluoroquinolone antibiotic ciprofloxacin. It is formed through the oxidation of ciprofloxacin, resulting in the conversion of one of its piperazinyl substituents to a ketone group. Oxociprofloxacin exhibits similar antimicrobial activity to ciprofloxacin and is effective against a broad range of bacterial infections.
Oxociprofloxacin (CAS 103237-52-1) References
- Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens. | Anadón, A., et al. 2001. Res Vet Sci. 71: 101-9. PMID: 11883887
- Transintestinal elimination of ciprofloxacin in humans--concomitant assessment of its metabolites in serum, ileum and colon. | Viell, B., et al. 1992. Infection. 20: 324-7. PMID: 1293050
- Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. | Vanwert, AL., et al. 2008. Mol Pharmacol. 74: 122-31. PMID: 18381565
- Ciprofloxacin: review on developments in synthetic, analytical, and medicinal aspects. | Sharma, PC., et al. 2010. J Enzyme Inhib Med Chem. 25: 577-89. PMID: 20235755
- Toxicity of the micropollutants Bisphenol A, Ciprofloxacin, Metoprolol and Sulfamethoxazole in water samples before and after the oxidative treatment. | Richard, J., et al. 2014. Int J Hyg Environ Health. 217: 506-14. PMID: 24211107
- Challenges in implementing a screening method for veterinary drugs in milk using liquid chromatography quadrupole time-of-flight mass spectrometry. | Turnipseed, SB., et al. 2014. J Agric Food Chem. 62: 3660-74. PMID: 24432774
- Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite group. | Yu, H., et al. 2015. Drug Metab Dispos. 43: 620-30. PMID: 25655830
- Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function. | Bergan, T., et al. 1989. Chemotherapy. 35: 393-405. PMID: 2612228
- Molecularly imprinted pipette-tip solid phase extraction for selective determination of fluoroquinolones in human urine using HPLC-DAD. | de Oliveira, HL., et al. 2016. J Chromatogr B Analyt Technol Biomed Life Sci. 1033-1034: 27-39. PMID: 27517523
- Different methods of incorporating ciprofloxacin in soil affect microbiome and degradation of ciprofloxacin residue. | Liu, L., et al. 2018. Sci Total Environ. 619-620: 1673-1681. PMID: 29056384
- High-performance liquid chromatography of ciprofloxacin and its metabolites in serum, urine and sputum. | Myers, CM. and Blumer, JL. 1987. J Chromatogr. 422: 153-64. PMID: 3437004
- Nontargeted screening of veterinary drugs and their metabolites in milk based on mass defect filtering using liquid chromatography-high-resolution mass spectrometry. | Chen, T., et al. 2022. Electrophoresis. 43: 1822-1831. PMID: 34894354
- Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection. | Kamberi, M., et al. 1998. Clin Chem. 44: 1251-5. PMID: 9625049
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Oxociprofloxacin, 10 mg | sc-208139 | 10 mg | $342.00 |